Vaxxinity, Inc. (OTCMKTS:VAXX – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.01 and traded as low as $0.0010. Vaxxinity shares last traded at $0.0010, with a volume of 219 shares trading hands.
Vaxxinity Trading Down 93.3%
The stock has a 50 day moving average of $0.01 and a 200-day moving average of $0.01. The stock has a market capitalization of $126,748.00, a P/E ratio of -0.01 and a beta of -71.72.
About Vaxxinity
Vaxxinity Inc. is a biotechnology company focused on developing vaccines and immunotherapies for chronic diseases, including neurodegenerative conditions. The company’s approach is designed to stimulate the body’s immune system to target disease-related proteins or pathways, with the goal of addressing underlying disease biology rather than treating symptoms alone. Vaxxinity’s research and development pipeline has included UB-311, an investigational vaccine targeting amyloid beta for Alzheimer’s disease, and UB-312, an investigational vaccine designed to target abnormal alpha-synuclein associated with Parkinson’s disease and other synucleinopathies.
Recommended Stories
- Five stocks we like better than Vaxxinity
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Vaxxinity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaxxinity and related companies with MarketBeat.com's FREE daily email newsletter.
